25 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
by Section 4.19(d), as promptly as reasonably possible under the circumstances taking into account the Company’s good faith assessment of any adverse
8-K
EX-99.1
0e7 myg1zq9
19 Mar 24
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
8:21am
8-K
EX-10.1
e16c7mow p9i5yayj6
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
DEF 14A
9y0hojs9
19 May 23
Definitive proxy
4:31pm
8-K
EX-99.1
fmzvkmx
16 May 23
Regulation FD Disclosure
7:47am
10-Q
irzojew
10 May 23
Quarterly report
7:14am
10-K
z1034dbyq nphbzvau
29 Mar 23
Annual report
4:08pm
424B4
8l4xn8os 5n
30 Dec 22
Prospectus supplement with pricing info
4:17pm
FWP
3lrdk 6n3vu1bf9
6 Dec 22
Free writing prospectus
4:17pm
S-1/A
0qt2vwuh4e1
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-2.1
ih1bmrildfns
18 Nov 22
IPO registration
5:06pm